ReviewNature reviews. Clinical oncology2024
Claudin 18.2 as a novel therapeutic target.
Izuma Nakayama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
150 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewNature reviews. Clinical oncology2024
Izuma Nakayama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.